Smoking Cessation and Incident Cardiovascular Disease

Authors:

Top Cited Papers
Open Access
Abstract
Cardiovascular disease (CVD) is among the leading causes of death globally, and the health care and social burdens of CVD are continuously increasing.1 Smoking is a leading risk factor, and an important modifiable risk factor, for CVD.1,2 Smoking causes more than 8 million deaths worldwide each year,3 and among adults aged 30 to 44 years who died from ischemic heart disease, 38% of the deaths were attributed to smoking.4 As smoking cessation may reduce CVD risk,5,6 guidelines strongly recommend smoking cessation for primary and secondary prevention of CVD.7,8 Due to smoking cessation counseling, nicotine replacement therapy, and medication, along with improvements in cultural and social awareness, the smoking rate, which was 32.7% of global adult population in 2000, decreased to 22.3% in 2020.4 Similarly, in South Korea, the smoking rate decreased from 25.8% in 2012 to 20.6% in 2020.9 However, the potential benefits of smoking cessation on CVD risk modification have not yet been fully elucidated, especially in terms of lifetime smoking burden (pack-years [PY]) and temporal changes in CVD risk.

This publication has 25 references indexed in Scilit: